Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8722691 Azolopyrimidines as inhibitors of cannabinoid 1 activity

Patent 8722691 was granted and assigned to IRM on May, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 9 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11891388 Pyrazolopyridine compounds and uses thereof
0
Edits on 12 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11866426 Benzothiazole compounds and uses thereof
0
Edits on 2 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 2 Dec, 2023
Edits made to:
Article (+296 characters)
Article

Patent abstract

The invention provides compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1). The compounds are of the Formulae Ia, Ic, Ig and Ik:

Edits on 19 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11787784 Solid forms of an HPK1 inhibitor
Edits on 25 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
David Archer Ellis0
Hong Liu0
Kunyong Yang0
Xiaohui He0
Edits on 24 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08722691 Azolopyrimidines as inhibitors of cannabinoid 1 activity US Patent 8722691 Azolopyrimidines as inhibitors of cannabinoid 1 activity

Infobox
Patent Number
087226910
Patent Number
87226910
Edits on 22 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=087226910
Edits on 7 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 7 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
‌
IRM
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
087226910
Date of Patent
May 13, 2014
0
Patent Application Number
122955550
Date Filed
March 30, 2007
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=087226910
Patent Primary Examiner
‌
Susanna Moore
0
Edits on 19 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 19 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=08722691
Edits on 23 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 23 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 08722691 Azolopyrimidines as inhibitors of cannabinoid 1 activity

Infobox
Is a
Patent
Patent
Current assignee
‌
IRM
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08722691
Date of patent
May 13, 2014
Patent application number
12295555
Date Filed
March 30, 2007
Patent primary examiner
‌
Susanna Moore

Find more entities like US Patent 8722691 Azolopyrimidines as inhibitors of cannabinoid 1 activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.